OnKure Director Edward T. Mathers Receives 22,350-Share Award

What Happened

• Edward T. Mathers, a director of OnKure Therapeutics, was granted a derivative award for 22,350 shares on 2026-08-07. The grant is reported as acquired at $0.00 per share (total reported value $0) and is coded as an award/grant (code A). This is an equity award subject to vesting, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-08-07; Form 4 filed: 2026-08-11 (filed within the standard 2-business-day window).
• Award: 22,350 shares reported as a derivative award at $0.00 per share (reported value $0).
• Vesting: 100% of the shares vest on the earlier of June 4, 2027 or the day prior to the issuer’s next annual meeting of stockholders, contingent on continued service (see footnote).
• Shares owned after transaction: Not disclosed in this filing.
• Transaction code: A = Award/Grant (not a purchase or sale).

Context

• This filing reports a time-vesting equity award to a director. Because the shares are subject to future vesting, they do not represent immediately marketable shares or proceeds. Such grants are common for compensating directors and do not necessarily signal a buy/sell intent.
• For retail investors: awards show management compensation alignment with shareholders but are different from outright purchases (which may indicate a direct bullish personal investment).